CG Oncology shares jump on positive clinical trial data for cancer drug
The U.S. Food and Drug Administration (FDA) granted cretostimogene Fast Track and Breakthrough Therapy designations
Health & Science
Medical and Pharmaceutical
Medical and pharmaceutical developments, psychedelics, and the research and safety questions around them.
Page 9
Innovent Biologics secures 2nd NDA approval for lung cancer drug as 1st‑line treatment
China's National Medical Products Administration approved the initial new drug application in January
Novocure sees 6% spike from EU nod for electric lung cancer therapy gadget
The Swiss company's Optune Lua device received FDA approval last fall
Kairos Pharma gets US$876K DoD grant for lung cancer treatment resistance research
The company has developed an antibody to fight against a protein that makes lung cancer cells resistant to drugs
Alarming CT radiation study highlights need for alternative diagnostic tools
University of California researchers have determined that these machines can cause 1 out of every 20 new cancer cases
How could a simple blood test could eliminate tumour biopsies?
The company has received support from the Centre of Expertise in Advanced Materials and Sustainability and Innovate UK
Lung cancer breath test demonstrates remarkable efficacy in Dutch study
It correctly identified positive cases with 80 to 92% accuracy
Smokers skipping lung cancer screenings: study
Lung cancer remains the leading cause of cancer death in the United States
60 Degrees Pharma signs patent agreement with Yale for tick disease medicine development
The newly announced partnership sent shares up by 137% at the intraday peak on the Nasdaq Tuesday
Long overdue lung cancer screening program coming to PEI, health minister says
It will get phased in within the next 2 years
Former nuclear test site workers advised to get screened for lung cancer
The Worker Health Protection Program's screening initiative has helped catch cases linked to radiation exposure in their early stages
Median Technologies clears hurdle on the way to regulatory acceptance in EU and US
The company has met a key requirement for regulatory submissions in the US and Europe
Corcept Therapeutics shares double on solid Phase 3 results for ovarian cancer treatment
Relacorilant is designed to address disorders linked to the stress hormone cortisol
More X‑ray referrals = more lung cancer survivors, study finds
The disease can often be eliminated through surgery or targeted radiation in its early stages
Soleno Therapeutics pulls in FDA nod for treatment for rare genetic disease
This approval is a hard-won victory for Soleno after a lengthy clinical trial phase
South Korean research institution develops lung cancer breath test with 95% accuracy
It uses a machine with 70 sensors to detect volatile organic compounds associated with the disease
NRx Pharmaceuticals submits NDA for intravenous ketamine drug
This therapeutic is specifically designed for suicidal depression
Chicago woman's shock lung cancer diagnosis inspires her to spread awareness
Thankfully, early detection and treatment measures are bringing hope to people who receive the unfortunate news
Is Cardiff Oncology 15% bump due to positive clinical trials or a short squeeze?
Individual biotech stocks often decouple from macro trends when company developments or investor enthusiasm take center stage
Indiana's 'Fight for Air Climb' raises over US$210K to combat lung diseases
More than 480 residents participated in the American Lung Association's annual event
Checkpoint Therapeutics gets picked up by Sun Pharma, enjoys 60% share bump
The deal could provide shareholders with an extra $0.70 per share if company's drug gains regulatory approval in Europe
Hawaii's new Advanced Lung Institute will cut surgery wait time from 8 weeks to hours
It features the state's first AI-powered lung nodule detection program
Indiana's first lung cancer screening truck hits the road
"A truly MONUMENTAL day," said a representative from the IU Simon Comprehensive Cancer Center
Nuvation Bio scoops US$250M financing to launch promising lung cancer therapeutic
Taletrectinib is the most advanced drug in the company's pipeline
TG Therapeutics stock spikes on strong financials and optimism for its flagship drug
The company's product for relapsing forms of multiple sclerosis (RMS), is its primary source of its most recent success
Medtronic explores global options to escape Trump tariffs
Trump imposed 25 per cent duties on imports from Mexico and Canada, set to take effect in March
Poor people die of cancer more than rich: UK research
Nearly half of the 28,400 additional cancer deaths linked to deprivation are due to lung cancer
Pulmonx Corporation shares spike on record-breaking Q4 revenue
Pulmonx achieved USD$83.8 million in worldwide revenue, reflecting a robust 22 per cent growth over 2023
New Korean cancer tech finds mutations with only a few drops of blood
In a clinical trial with blood from 83 patients, the test identified 100 per cent of EGFR gene mutations
Early lung cancer diagnosis saves 52‑year‑old Indian man's life
A persistent cough and breathlessness while climbing stairs prompted him to visit the hospital
PEI needs to jump on lung cancer screening bandwagon ASAP, advocate says
It is the last Canadian province without a program for catching the disease
British scientists develop lung cancer blood test that gives results in 40 minutes
This new screening device is the product of a 3-year study from Cranfield University scholars
Lipella Pharmaceuticals skyrockets on FDA access approval for mouth disease treatment
The stock was up by about 200% during early trading hours
Obesity reduces risk of dying from lung cancer by 21%, South Korean study finds
The investigators examined data from more than 7,000 patients over an 11-year period to make this determination
FDA gives Zai Lab's small cell lung cancer therapeutic orphan drug designation
About 372,000 people are diagnosed with SCLC annually worldwide
Deep learning AI model proves itself useful for CT imaging tumour analysis
It was trained by examining over 1,500 CT scans
bioAffinity Technologies secures Australian patent for 'CyPath Lung' spit test
It will be issued within 3 months provided that there are no opposition filings made by third parties
University of Waterloo and Princess Margaret Cancer Centre collaborate on innovative cancer research
The Canadian Cancer Society reports that healthcare professionals diagnose over 100 types of cancer-related diseases each year
Innovent and ASK Pharm scoop Chinese regulator approval for oral lung cancer drug
'Limertinib' targets non-small cell lung cancer with a particular mutation that is prevalent in Asian patients
Baird Medical rubs shoulders with investors at prestigious healthcare event, sees 77% spike
The annual J.P. Morgan Healthcare Conference is held in San Francisco